Browsing: Business
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical…
Below is a weekly roundup of what happened this week in the cannabis and psychedelic sectors. In this ever-evolving landscape,…
Shanghai, China–(Newsfile Corp. – March 3, 2025) – From July 16 to 18, 2025, the 12th Aviation Power and Gas…
We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are…
By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the first China-approved third-generation BCR-ABL inhibitor,…
Release Date: March 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call…
We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are…
Robinhood Markets reported strong fourth-quarter 2024 earnings on February 12, leading to an impressive 12% price movement in its shares…